Back to top

Image: Bigstock

New Strong Buy Stocks for November 10th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Arch Capital Group Ltd. (ACGL - Free Report) : This diversified financial services holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.4% over the last 30 days.

ARCH CAP GP LTD Price and Consensus

 

ARCH CAP GP LTD Price and Consensus | ARCH CAP GP LTD Quote

Bruker Corporation (BRKR - Free Report) : This scientific instruments, and analytical and diagnostic solutions provider has witnessed the Zacks Consensus Estimate for its current year earnings jumping nearly 9.2% over the last 30 days.

BRUKER CORP Price and Consensus

 

BRUKER CORP Price and Consensus | BRUKER CORP Quote

The Chemours Company (CC - Free Report) : This performance chemicals provider has seen the Zacks Consensus Estimate for its current year earnings gaining 6.3% over the last 30 days.

CHEMOURS COMPNY Price and Consensus

 

CHEMOURS COMPNY Price and Consensus | CHEMOURS COMPNY Quote

ZELTIQ Aesthetics, Inc. : This medical technology company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3% over the last 30 days.

ZELTIQ AESTHETC Price and Consensus

 

ZELTIQ AESTHETC Price and Consensus | ZELTIQ AESTHETC Quote

Best Buy Co., Inc. (BBY - Free Report) : This technology product retailer has seen the Zacks Consensus Estimate revision for its current year earnings rising 0.3% over the last 60 days.

BEST BUY Price and Consensus

 

BEST BUY Price and Consensus | BEST BUY Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want to see all of today's Zacks Strong Buys?

Today's 5 additions are just the appetizer. You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research. See the stocks free >>.

Published in